STIM

Neuronetics (STIM)

Neuronetics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:STIM

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/31	05:01	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NASDAQ:STIM	Neuronetics Inc
2024/05/23	21:30	GlobeNewswire Inc.	Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference	NASDAQ:STIM	Neuronetics Inc
2024/05/15	20:32	GlobeNewswire Inc.	Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents	NASDAQ:STIM	Neuronetics Inc
2024/05/08	05:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:STIM	Neuronetics Inc
2024/05/07	20:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STIM	Neuronetics Inc
2024/05/07	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STIM	Neuronetics Inc
2024/05/07	20:30	GlobeNewswire Inc.	Neuronetics Reports Record First Quarter 2024 Financial and Operating Results	NASDAQ:STIM	Neuronetics Inc
2024/05/04	05:30	GlobeNewswire Inc.	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:STIM	Neuronetics Inc
2024/05/01	21:31	GlobeNewswire Inc.	NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month	NASDAQ:STIM	Neuronetics Inc
2024/04/24	05:30	GlobeNewswire Inc.	Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call	NASDAQ:STIM	Neuronetics Inc
2024/04/10	21:31	GlobeNewswire Inc.	New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital	NASDAQ:STIM	Neuronetics Inc
2024/03/28	05:30	GlobeNewswire Inc.	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:STIM	Neuronetics Inc
2024/03/25	21:30	GlobeNewswire Inc.	NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression	NASDAQ:STIM	Neuronetics Inc
2024/03/07	22:22	GlobeNewswire Inc.	Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network	NASDAQ:STIM	Neuronetics Inc
2024/03/07	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STIM	Neuronetics Inc
2024/03/05	21:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STIM	Neuronetics Inc
2024/03/05	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STIM	Neuronetics Inc
2024/03/05	21:30	GlobeNewswire Inc.	Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results	NASDAQ:STIM	Neuronetics Inc
2024/03/02	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc
2024/03/02	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc
2024/03/01	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc
2024/03/01	06:10	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STIM	Neuronetics Inc
2024/02/29	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc
2024/02/29	06:48	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STIM	Neuronetics Inc
2024/02/29	06:16	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STIM	Neuronetics Inc
2024/02/28	07:33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STIM	Neuronetics Inc
2024/02/27	07:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc
2024/02/27	06:54	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STIM	Neuronetics Inc
2024/02/24	06:23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STIM	Neuronetics Inc
2024/02/23	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc